Conexeu Sciences Inc. income statement CNXU

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line
FY 2026
Jul 31, 2026
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

Company profile

Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
Listed as
CNXU (Nasdaq)
Fiscal year ends
October 31
Incorporated in
NV
Headquarters
Reno, NV
SEC filer status
, Emerging growth company
SEC CIK
2066836

Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.